Hepatitis

This Power Point presentation contains 181 slides that provide guidelines for the prevention and control of TB in correctional facilities, as recommended by CDC.

This slide set is an audiovisual educational tool that explains the importance of getting babies vaccinated against hepatitis B. It discusses hepatitis transmission, testing for the pregnant woman to determine if she has hepatitis B, and routine hepatitis B vaccine for babies.

This report describes CDC comparison of acute hepatitis C virus (HCV) surveillance data reported in 2008 from the National Notifiable Diseases Surveillance System (NNDS) and the Emerging Infections Program (EIP), which conducts enhanced surveillance for acute hepatitis C in selected states. Results show that 26 of 120 cases reported from EIP-funded sites were missing from NNDSS. Data on race and major HCV risk factors were missing from 22 percent and 60 percent of reports in NNDSS, compared with 8 percent and 25 percent of reports in EIP, respectively.

In this study, CDC reports on assessed hepatitis A vaccine coverage among children aged 12-23 months from 2006-2009, using data from eight Immunization Information System sentinel sites. Average hepatitis A vaccination coverage with =1 dose at the sites increased from 17 percent in 2006 to 47 percent in 2009. Average full vaccination coverage with =2 vaccine doses through age 23 months increased from one percent in 2006 to 15 percent in 2009. Vaccine coverage with =1 dose increased most during 2006 through the first quarter of 2007, then slowed.

This study discusses information on the 184 syringe exchange programs (SEPs) operating in 36 states, the District of Columbia, and Puerto Rico. Of these SEPs, 67% completed a mail/telephone survey conducted by North American Syringe Exchange Network (NASEN) and Beth Israel Medical Center, New York, which covered program operations for 2008. The report summarizes findings from the survey and compares them with results from a previous SEP survey for 1994-2007.

This series of patient education fact sheets provides information on drugs used in the treatment of TB (e.g., Clofazimine, Ethambutol, Ethionamide, Isoniazid, Levofloxacin, Moxifloxacin, PASER [p-aminosalicylic acid granules], Pyrazinamide, Pyridoxine, Rifabutin, Rifampin, Streptomycin). The fact sheets include information on medication side effects, actions to take if side effects occur, and instructions in the event a dose of medication is missed.

Dr. Mark Gilbert of the BC Centre for Disease Control talks about tuberculosis in a minute-long video.

An infographic with information on latent TB, TB disease, TB in British Columbia, TB globally, and TB symptoms,

Dr. Mark Gilbert of the BC Centre for Disease Control talks about the prevalence of tuberculosis in British Columbia.

A fact sheet on the TB skin test, including information on latent TB infection, TB disease, and what a positive/negative skin test means. The fact sheet also has information on testing after receiving the BCG vaccine.